nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—ACE—umbilical vein—melanoma	0.063	0.173	CbGeAlD
Rescinnamine—ACE—hindlimb—melanoma	0.0577	0.159	CbGeAlD
Rescinnamine—ACE—arm—melanoma	0.0551	0.152	CbGeAlD
Rescinnamine—Sunburn—Vemurafenib—melanoma	0.0504	0.0802	CcSEcCtD
Rescinnamine—ACE—appendage—melanoma	0.0495	0.136	CbGeAlD
Rescinnamine—Tearing eyes—Docetaxel—melanoma	0.0315	0.0502	CcSEcCtD
Rescinnamine—ACE—endothelium—melanoma	0.0299	0.0822	CbGeAlD
Rescinnamine—ACE—blood vessel—melanoma	0.0276	0.0758	CbGeAlD
Rescinnamine—Pigmentation disorder—Temozolomide—melanoma	0.0233	0.0371	CcSEcCtD
Rescinnamine—ACE—neck—melanoma	0.0197	0.0542	CbGeAlD
Rescinnamine—Skin hyperpigmentation—Bleomycin—melanoma	0.0155	0.0247	CcSEcCtD
Rescinnamine—ACE—eye—melanoma	0.0147	0.0403	CbGeAlD
Rescinnamine—Skin hyperpigmentation—Carmustine—melanoma	0.0135	0.0215	CcSEcCtD
Rescinnamine—Bullous eruption—Docetaxel—melanoma	0.0131	0.0208	CcSEcCtD
Rescinnamine—SLC18A2—head—melanoma	0.0122	0.0335	CbGeAlD
Rescinnamine—Tooth disorder—Temozolomide—melanoma	0.012	0.0191	CcSEcCtD
Rescinnamine—ACE—mammalian vulva—melanoma	0.0116	0.032	CbGeAlD
Rescinnamine—Herpes zoster—Temozolomide—melanoma	0.0103	0.0164	CcSEcCtD
Rescinnamine—Abscess—Carmustine—melanoma	0.0102	0.0162	CcSEcCtD
Rescinnamine—Endocrine disorder—Temozolomide—melanoma	0.00938	0.0149	CcSEcCtD
Rescinnamine—Accidental injury—Carmustine—melanoma	0.00909	0.0145	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Vemurafenib—melanoma	0.00871	0.0139	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Docetaxel—melanoma	0.00869	0.0138	CcSEcCtD
Rescinnamine—SLC18A2—lymph node—melanoma	0.00854	0.0235	CbGeAlD
Rescinnamine—ACE—head—melanoma	0.00833	0.0229	CbGeAlD
Rescinnamine—Vaginal inflammation—Temozolomide—melanoma	0.00777	0.0124	CcSEcCtD
Rescinnamine—Redness—Docetaxel—melanoma	0.00766	0.0122	CcSEcCtD
Rescinnamine—Vaginal infection—Temozolomide—melanoma	0.00734	0.0117	CcSEcCtD
Rescinnamine—Injury—Bleomycin—melanoma	0.00728	0.0116	CcSEcCtD
Rescinnamine—Erythema—Vemurafenib—melanoma	0.00665	0.0106	CcSEcCtD
Rescinnamine—Dysgeusia—Vemurafenib—melanoma	0.00651	0.0104	CcSEcCtD
Rescinnamine—Back pain—Vemurafenib—melanoma	0.00643	0.0102	CcSEcCtD
Rescinnamine—Injury—Carmustine—melanoma	0.00635	0.0101	CcSEcCtD
Rescinnamine—Eye irritation—Docetaxel—melanoma	0.00605	0.00964	CcSEcCtD
Rescinnamine—ACE—lymph node—melanoma	0.00583	0.016	CbGeAlD
Rescinnamine—Cough—Vemurafenib—melanoma	0.0058	0.00924	CcSEcCtD
Rescinnamine—Myalgia—Vemurafenib—melanoma	0.00566	0.00901	CcSEcCtD
Rescinnamine—Lacrimation increased—Docetaxel—melanoma	0.00561	0.00893	CcSEcCtD
Rescinnamine—Voacamine—ABCB1—melanoma	0.0054	0.648	CrCbGaD
Rescinnamine—Infection—Vemurafenib—melanoma	0.00539	0.00858	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Bleomycin—melanoma	0.00508	0.00809	CcSEcCtD
Rescinnamine—Myocardial infarction—Bleomycin—melanoma	0.00505	0.00805	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00494	0.00787	CcSEcCtD
Rescinnamine—Bronchitis—Temozolomide—melanoma	0.00469	0.00747	CcSEcCtD
Rescinnamine—Constipation—Vemurafenib—melanoma	0.00464	0.00739	CcSEcCtD
Rescinnamine—Hypoaesthesia—Bleomycin—melanoma	0.0046	0.00733	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Temozolomide—melanoma	0.00445	0.00709	CcSEcCtD
Rescinnamine—Urinary tract infection—Carmustine—melanoma	0.00437	0.00696	CcSEcCtD
Rescinnamine—Pharyngitis—Dactinomycin—melanoma	0.00428	0.00682	CcSEcCtD
Rescinnamine—Urinary tract infection—Temozolomide—melanoma	0.00423	0.00673	CcSEcCtD
Rescinnamine—Sinusitis—Temozolomide—melanoma	0.00408	0.0065	CcSEcCtD
Rescinnamine—Erythema—Bleomycin—melanoma	0.00403	0.00641	CcSEcCtD
Rescinnamine—Hypoaesthesia—Carmustine—melanoma	0.00402	0.0064	CcSEcCtD
Rescinnamine—Hypersensitivity—Vemurafenib—melanoma	0.004	0.00637	CcSEcCtD
Rescinnamine—Dermatitis bullous—Docetaxel—melanoma	0.00393	0.00625	CcSEcCtD
Rescinnamine—Hypoaesthesia—Temozolomide—melanoma	0.00388	0.00618	CcSEcCtD
Rescinnamine—Pharyngitis—Temozolomide—melanoma	0.00387	0.00617	CcSEcCtD
Rescinnamine—Pruritus—Vemurafenib—melanoma	0.00384	0.00611	CcSEcCtD
Rescinnamine—Erythema—Dactinomycin—melanoma	0.00376	0.00598	CcSEcCtD
Rescinnamine—Dizziness—Vemurafenib—melanoma	0.00359	0.00571	CcSEcCtD
Rescinnamine—Erythema—Carmustine—melanoma	0.00352	0.0056	CcSEcCtD
Rescinnamine—Cough—Bleomycin—melanoma	0.00352	0.0056	CcSEcCtD
Rescinnamine—Myalgia—Bleomycin—melanoma	0.00343	0.00546	CcSEcCtD
Rescinnamine—Rash—Vemurafenib—melanoma	0.00342	0.00545	CcSEcCtD
Rescinnamine—Dermatitis—Vemurafenib—melanoma	0.00342	0.00544	CcSEcCtD
Rescinnamine—Back pain—Carmustine—melanoma	0.0034	0.00542	CcSEcCtD
Rescinnamine—Headache—Vemurafenib—melanoma	0.0034	0.00541	CcSEcCtD
Rescinnamine—Erythema—Temozolomide—melanoma	0.0034	0.00541	CcSEcCtD
Rescinnamine—Discomfort—Bleomycin—melanoma	0.00339	0.0054	CcSEcCtD
Rescinnamine—Dysgeusia—Temozolomide—melanoma	0.00333	0.0053	CcSEcCtD
Rescinnamine—Oedema—Bleomycin—melanoma	0.00329	0.00524	CcSEcCtD
Rescinnamine—Back pain—Temozolomide—melanoma	0.00329	0.00523	CcSEcCtD
Rescinnamine—Infection—Bleomycin—melanoma	0.00327	0.0052	CcSEcCtD
Rescinnamine—Nausea—Vemurafenib—melanoma	0.00322	0.00513	CcSEcCtD
Rescinnamine—Myalgia—Dactinomycin—melanoma	0.0032	0.00509	CcSEcCtD
Rescinnamine—Discomfort—Dactinomycin—melanoma	0.00316	0.00503	CcSEcCtD
Rescinnamine—Angina pectoris—Docetaxel—melanoma	0.00316	0.00503	CcSEcCtD
Rescinnamine—Oedema—Dactinomycin—melanoma	0.00307	0.00488	CcSEcCtD
Rescinnamine—Infection—Dactinomycin—melanoma	0.00305	0.00485	CcSEcCtD
Rescinnamine—Hypertension—Carmustine—melanoma	0.00304	0.00483	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Bleomycin—melanoma	0.003	0.00477	CcSEcCtD
Rescinnamine—Myalgia—Carmustine—melanoma	0.00299	0.00477	CcSEcCtD
Rescinnamine—Cough—Temozolomide—melanoma	0.00297	0.00472	CcSEcCtD
Rescinnamine—Paraesthesia—Bleomycin—melanoma	0.00295	0.0047	CcSEcCtD
Rescinnamine—Reserpine—ABCB1—melanoma	0.00294	0.353	CrCbGaD
Rescinnamine—Hypertension—Temozolomide—melanoma	0.00293	0.00467	CcSEcCtD
Rescinnamine—Myalgia—Temozolomide—melanoma	0.00289	0.00461	CcSEcCtD
Rescinnamine—Oedema—Carmustine—melanoma	0.00287	0.00457	CcSEcCtD
Rescinnamine—Discomfort—Temozolomide—melanoma	0.00286	0.00455	CcSEcCtD
Rescinnamine—Infection—Carmustine—melanoma	0.00285	0.00454	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Docetaxel—melanoma	0.00285	0.00454	CcSEcCtD
Rescinnamine—Myocardial infarction—Docetaxel—melanoma	0.00283	0.00451	CcSEcCtD
Rescinnamine—Pain—Bleomycin—melanoma	0.00281	0.00448	CcSEcCtD
Rescinnamine—Conjunctivitis—Docetaxel—melanoma	0.00281	0.00448	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00279	0.00445	CcSEcCtD
Rescinnamine—Oedema—Temozolomide—melanoma	0.00277	0.00442	CcSEcCtD
Rescinnamine—Infection—Temozolomide—melanoma	0.00276	0.00439	CcSEcCtD
Rescinnamine—Pain—Dactinomycin—melanoma	0.00262	0.00418	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Carmustine—melanoma	0.00261	0.00416	CcSEcCtD
Rescinnamine—Urticaria—Bleomycin—melanoma	0.00261	0.00416	CcSEcCtD
Rescinnamine—Rhinitis—Docetaxel—melanoma	0.0026	0.00414	CcSEcCtD
Rescinnamine—Insomnia—Carmustine—melanoma	0.0026	0.00413	CcSEcCtD
Rescinnamine—Hypoaesthesia—Docetaxel—melanoma	0.00258	0.00411	CcSEcCtD
Rescinnamine—Paraesthesia—Carmustine—melanoma	0.00258	0.0041	CcSEcCtD
Rescinnamine—Pharyngitis—Docetaxel—melanoma	0.00258	0.0041	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Temozolomide—melanoma	0.00253	0.00402	CcSEcCtD
Rescinnamine—Insomnia—Temozolomide—melanoma	0.00251	0.00399	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Dactinomycin—melanoma	0.00251	0.00399	CcSEcCtD
Rescinnamine—Paraesthesia—Temozolomide—melanoma	0.00249	0.00397	CcSEcCtD
Rescinnamine—Pain—Carmustine—melanoma	0.00245	0.00391	CcSEcCtD
Rescinnamine—Constipation—Carmustine—melanoma	0.00245	0.00391	CcSEcCtD
Rescinnamine—Abdominal pain—Dactinomycin—melanoma	0.00242	0.00386	CcSEcCtD
Rescinnamine—Hypersensitivity—Bleomycin—melanoma	0.00242	0.00386	CcSEcCtD
Rescinnamine—Pain—Temozolomide—melanoma	0.00237	0.00378	CcSEcCtD
Rescinnamine—Constipation—Temozolomide—melanoma	0.00237	0.00378	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Carmustine—melanoma	0.00235	0.00374	CcSEcCtD
Rescinnamine—Pruritus—Bleomycin—melanoma	0.00233	0.0037	CcSEcCtD
Rescinnamine—Abdominal pain—Carmustine—melanoma	0.00227	0.00361	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Temozolomide—melanoma	0.00227	0.00361	CcSEcCtD
Rescinnamine—Erythema—Docetaxel—melanoma	0.00226	0.0036	CcSEcCtD
Rescinnamine—Hypersensitivity—Dactinomycin—melanoma	0.00226	0.0036	CcSEcCtD
Rescinnamine—Dysgeusia—Docetaxel—melanoma	0.00221	0.00352	CcSEcCtD
Rescinnamine—Urticaria—Temozolomide—melanoma	0.0022	0.00351	CcSEcCtD
Rescinnamine—Abdominal pain—Temozolomide—melanoma	0.00219	0.00349	CcSEcCtD
Rescinnamine—Back pain—Docetaxel—melanoma	0.00219	0.00348	CcSEcCtD
Rescinnamine—Hypersensitivity—Carmustine—melanoma	0.00211	0.00337	CcSEcCtD
Rescinnamine—Rash—Bleomycin—melanoma	0.00207	0.0033	CcSEcCtD
Rescinnamine—Dermatitis—Bleomycin—melanoma	0.00207	0.0033	CcSEcCtD
Rescinnamine—Hypersensitivity—Temozolomide—melanoma	0.00204	0.00325	CcSEcCtD
Rescinnamine—Cough—Docetaxel—melanoma	0.00197	0.00314	CcSEcCtD
Rescinnamine—Pruritus—Temozolomide—melanoma	0.00196	0.00312	CcSEcCtD
Rescinnamine—Nausea—Bleomycin—melanoma	0.00195	0.00311	CcSEcCtD
Rescinnamine—Hypertension—Docetaxel—melanoma	0.00195	0.00311	CcSEcCtD
Rescinnamine—Rash—Dactinomycin—melanoma	0.00193	0.00308	CcSEcCtD
Rescinnamine—Myalgia—Docetaxel—melanoma	0.00192	0.00306	CcSEcCtD
Rescinnamine—Dizziness—Carmustine—melanoma	0.0019	0.00302	CcSEcCtD
Rescinnamine—Oedema—Docetaxel—melanoma	0.00184	0.00294	CcSEcCtD
Rescinnamine—Dizziness—Temozolomide—melanoma	0.00183	0.00292	CcSEcCtD
Rescinnamine—Infection—Docetaxel—melanoma	0.00183	0.00292	CcSEcCtD
Rescinnamine—Nausea—Dactinomycin—melanoma	0.00182	0.0029	CcSEcCtD
Rescinnamine—Rash—Carmustine—melanoma	0.00181	0.00288	CcSEcCtD
Rescinnamine—Dermatitis—Carmustine—melanoma	0.00181	0.00288	CcSEcCtD
Rescinnamine—Headache—Carmustine—melanoma	0.0018	0.00286	CcSEcCtD
Rescinnamine—Rash—Temozolomide—melanoma	0.00175	0.00278	CcSEcCtD
Rescinnamine—Dermatitis—Temozolomide—melanoma	0.00175	0.00278	CcSEcCtD
Rescinnamine—Headache—Temozolomide—melanoma	0.00174	0.00277	CcSEcCtD
Rescinnamine—Nausea—Carmustine—melanoma	0.0017	0.00271	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Docetaxel—melanoma	0.00168	0.00268	CcSEcCtD
Rescinnamine—Insomnia—Docetaxel—melanoma	0.00167	0.00266	CcSEcCtD
Rescinnamine—Paraesthesia—Docetaxel—melanoma	0.00166	0.00264	CcSEcCtD
Rescinnamine—Nausea—Temozolomide—melanoma	0.00165	0.00262	CcSEcCtD
Rescinnamine—Constipation—Docetaxel—melanoma	0.00158	0.00251	CcSEcCtD
Rescinnamine—Pain—Docetaxel—melanoma	0.00158	0.00251	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Docetaxel—melanoma	0.00151	0.0024	CcSEcCtD
Rescinnamine—Abdominal pain—Docetaxel—melanoma	0.00146	0.00232	CcSEcCtD
Rescinnamine—Hypersensitivity—Docetaxel—melanoma	0.00136	0.00216	CcSEcCtD
Rescinnamine—Pruritus—Docetaxel—melanoma	0.0013	0.00208	CcSEcCtD
Rescinnamine—Dizziness—Docetaxel—melanoma	0.00122	0.00194	CcSEcCtD
Rescinnamine—Rash—Docetaxel—melanoma	0.00116	0.00185	CcSEcCtD
Rescinnamine—Dermatitis—Docetaxel—melanoma	0.00116	0.00185	CcSEcCtD
Rescinnamine—Headache—Docetaxel—melanoma	0.00116	0.00184	CcSEcCtD
Rescinnamine—Nausea—Docetaxel—melanoma	0.0011	0.00174	CcSEcCtD
